Maximus (NYSE:MMS) Stock Lifted to “Hold” by Zacks Research

Maximus (NYSE:MMS) was upgraded by investment analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report issued on Thursday, Zacks reports.

A number of other equities analysts have also commented on MMS. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Maximus in a research note on Monday, August 17th. Wall Street Zen downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Two analysts have rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of “Hold”.

Maximus Stock Performance

NYSE MMS opened at $52.72 on Thursday. The company has a market capitalization of $2.76 billion, a price-to-earnings ratio of 7.79 and a beta of 0.59. Maximus has a twelve month low of $51.04 and a twelve month high of $100.00. The stock has a fifty day simple moving average of $57.31 and a 200 day simple moving average of $60.29. The company has a quick ratio of 2.42, a current ratio of 2.42 and a debt-to-equity ratio of 0.90.

Maximus (NYSE:MMS) last announced its earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.21 by $0.01. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The business had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.33 billion. During the same period last year, the company earned $2.16 EPS. Maximus’s revenue for the quarter was down 5.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. Sell-side analysts expect that Maximus will post 8.03 EPS for the current year.

Insiders Place Their Bets

In other Maximus news, insider Michelle Link sold 3,208 shares of Maximus stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $54.23, for a total value of $173,969.84. Following the completion of the sale, the insider directly owned 13,881 shares in the company, valued at approximately $752,766.63. The trade was a 18.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.80% of the company’s stock.

Hedge Funds Weigh In On Maximus

A number of institutional investors and hedge funds have recently modified their holdings of the business. Sequoia Financial Advisors LLC bought a new position in shares of Maximus during the 2nd quarter valued at approximately $294,000. WINTON GROUP Ltd lifted its holdings in Maximus by 1,992.2% during the second quarter. WINTON GROUP Ltd now owns 83,687 shares of the health services provider’s stock valued at $4,499,000 after purchasing an additional 79,687 shares during the last quarter. Engineers Gate Manager LP purchased a new position in shares of Maximus in the second quarter worth about $2,075,000. Integrated Wealth Concepts LLC bought a new stake in shares of Maximus in the second quarter valued at approximately $34,000. Finally, Squarepoint Ops LLC lifted its stake in shares of Maximus by 723.0% during the 2nd quarter. Squarepoint Ops LLC now owns 219,301 shares of the health services provider’s stock valued at $11,790,000 after buying an additional 192,655 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors.

About Maximus

Maximus, Inc (NYSE:MMS) is a provider of government services and technology-enabled solutions. The company partners with federal, state, provincial and local governments to administer public programs, improve service delivery and support interactions between governments and the people they serve.

Its business activities include health and human services administration, employment and workforce services, child support and eligibility services, customer contact centers, program management, consulting and digital transformation.